Increased healthcare utilization costs following initiation of insulin treatment in type 2 diabetes: A long-term follow-up in clinical practice.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Primary Care Diabetes

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.pcd.2016.11.002PMID 27894781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013

  2016cited by this paper
• Association Between Weight Change, Clinical Outcomes, and Health Care Costs in Patients with Type 2 Diabetes

  2016cited by this paper
• High daily insulin exposure in patients with type 2 diabetes is associated with increased risk of cardiovascular events.

  2015cited by this paper
• Glucose‐lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all‐cause mortality, cardiovascular events and cancer

  2015cited by this paper
• Second-line treatment with sulfonylurea compared to DPP4 inhibitors demonstrated associations with earlier treatment intensification with insulin

  2015cited by this paper
• Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study

  2015cited by this paper
• Healthcare utilization and costs following newly diagnosed type-2 diabetes in Sweden: A follow-up of 38,956 patients in a clinical practice setting.

  2015cited by this paper
• Association of Changes In Body Weight With Health Care Costs Among Patients With Newly-Diagnosed Type-2 Diabetes In Sweden.

  2014cited by this paper
• Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes.

  2014cited by this paper
• Type 2 Diabetes Treatment Patterns Across Europe.

  2014cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

  2014cited by this paper
• Changes of Body Mass Index in Relation to Mortality: Results of a Cohort of 42,099 Adults

  2014cited by this paper
• Annual Medical Costs of Swedish Patients with Type 2 Diabetes Before and After Insulin Initiation

  2013cited by this paper
• Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2013cited by this paper
• Associations of HbA1c and educational level with risk of cardiovascular events in 32 871 drug-treated patients with Type 2 diabetes: a cohort study in primary care

  2013cited by this paper
• Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8486 primary-care patients.

  2013cited by this paper
• Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: cohort study of 34 009 primary care patients

  2013cited by this paper
• Healthcare costs associated with change in body mass index in patients with type 2 diabetes mellitus in Spain: the ECOBIM study.

  2012cited by this paper
• Diabetes expenditure, burden of disease and management in 5 EU countries

  2012cited by this paper
• Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain

  2012cited by this paper
• β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy

  2012cited by this paper
• Association between glycemic control and short-term healthcare costs among commercially insured diabetes patients in the United States

  2011cited by this paper
• Severe hypoglycemia and risks of vascular events and death.

  2010cited by this paper
• Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.

  2010cited by this paper
• Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005—a register‐based approach

  2009cited by this paper
• Recent advances in the management of type 2 diabetes mellitus: a review

  2008cited by this paper
• Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients

  2008cited by this paper
• Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

  2008cited by this paper
• Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4‐year follow‐up

  2008cited by this paper
• Economic Costs of Diabetes in the U.S. in 2007

  2008cited by this paper
• Resource use and costs of type 2 diabetes in Sweden – estimates from population‐based register data

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Insulin‐associated weight gain in diabetes – causes, effects and coping strategies

  2007cited by this paper
• Quality of life of patients with diabetes mellitus An overview of research in primary health care in the Nordic countries

  2005cited by this paper
• The direct medical cost of type 2 diabetes.

  2003cited by this paper
• Assessing the impact of complications on the costs of Type II diabetes

  2002cited by this paper
• Revealing the cost of Type II diabetes in Europe.

  2002cited by this paper
• Revealing the cost of Type II diabetes in Europe

  2002cited by this paper
• Effect of insulin therapy on quality of life in Type 2 diabetes mellitus: The Fremantle Diabetes Study.

  2001cited by this paper
• Direct medical costs for patients with type 2 diabetes in Sweden

  2000cited by this paper
• Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis.

  1999cited by this paper
• Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry.

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper

• Risk of insulin initiation with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes mellitus: A real‐world claims database study in Japan

  2025cites this paper
• Laparoscopic Roux-en-Y gastric bypass for excess weight and diabetes: a multicenter retrospective cohort study in China

  2021cites this paper
• Characterizing health care utilization following hospitalization for a traumatic brain injury: a retrospective cohort study

  2020cites this paper
• Direct medical costs in the preceding, event and subsequent years of a first severe hypoglycaemia episode requiring hospitalization: A population‐based cohort study

  2019cites this paper
• Changes in health services usage associated with insulin initiation in primary care.

  2018cites this paper
• DIRECT COSTS OF TYPE 2 DIABETES: A BRAZILIAN COST-OF-ILLNESS STUDY

  2018cites this paper
• Type 2 diabetes, healthcare expenditures and its correlation with anthropometric factors and physical activity: 18-month follow-up in a Brazilian city

  2018cites this paper
• Weight change patterns and healthcare costs in patients with newly-diagnosed type-2 diabetes in Sweden.

  2017cites this paper